{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:51:18Z","timestamp":1772250678232,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.arcped.2017.12.003","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T18:45:09Z","timestamp":1517510709000},"page":"132-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hemodynamic support of a 15-year-old waiting for a heart transplant: Is there a role for levosimendan in pediatric heart failure?"],"prefix":"10.1016","volume":"25","author":[{"given":"I.","family":"Goyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Brossier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2017.12.003_bib0160","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.cjca.2013.08.008","article-title":"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society Guidelines","volume":"29","author":"Kantor","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.arcped.2017.12.003_bib0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1570161113666151014125314","article-title":"Inodilators in the management of low cardiac output syndrome after pediatric surgery","volume":"14","author":"Ferrer-Barba","year":"2016","journal-title":"Curr Vasc Phamacol"},{"key":"10.1016\/j.arcped.2017.12.003_bib0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2016.07.202","article-title":"Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper","volume":"222","author":"Farmakis","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.arcped.2017.12.003_bib0175","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.arcped.2016.05.002","article-title":"Utilisation du levosimendan chez l\u2019enfant","volume":"23","author":"S\u00e9gu\u00e9la","year":"2016","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2017.12.003_bib0180","series-title":"Product monograph Levosimendan (SimdaxMD)","author":"Orion Pharma","year":"2010"},{"key":"10.1016\/j.arcped.2017.12.003_bib0185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/jcpt.12067","article-title":"Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects","volume":"38","author":"Pathak","year":"2013","journal-title":"J Clin Pham Ther"},{"key":"10.1016\/j.arcped.2017.12.003_bib0190","doi-asserted-by":"crossref","first-page":"e85909","DOI":"10.1371\/journal.pone.0085909","article-title":"Inhibition of reverse-mode sodium-calcium exchanger activity and apoptosis by levosimendan in human cardiomyocyte progenitor cell-derived cardiomyocytes after anoxia and reoxygenation","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arcped.2017.12.003_bib0195","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.ajkd.2015.09.015","article-title":"Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials","volume":"67","author":"Zhou","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.arcped.2017.12.003_bib0200","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijcard.2014.04.111","article-title":"Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus","volume":"174","author":"Nieminen","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.arcped.2017.12.003_bib0205","series-title":"Levosimendan compassionate use in pediatric patients with advanced decompensated heart failure","author":"Tenax Therapeutics","year":"2016"},{"key":"10.1016\/j.arcped.2017.12.003_bib0210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejps.2004.07.005","article-title":"Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators","volume":"23","author":"Antila","year":"2004","journal-title":"Eur J Pharm Sci"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.arcped.2017.12.003_bib0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/PCC.0000000000000624","article-title":"Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: pharmacotherapies in cardiac critical care chronic heart failure","volume":"17","author":"Rossano","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.arcped.2017.12.003_bib0220","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jacc.2017.07.725","article-title":"Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure","volume":"70","author":"Bonnet","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arcped.2017.12.003_bib0225","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijcard.2008.08.020","article-title":"Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials","volume":"138","author":"Delaney","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.arcped.2017.12.003_bib0230","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/CCM.0b013e318232962a","article-title":"Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled trials","volume":"40","author":"Landoni","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.arcped.2017.12.003_bib0235","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/jocs.12562","article-title":"Levosimendan reduces mortality in adults with left ventricular dysfunction undergoing cardiac surgery: a systematic review and meta-analysis","volume":"30","author":"Lim","year":"2015","journal-title":"J Card Surg"},{"key":"10.1016\/j.arcped.2017.12.003_bib0240","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/bja\/aeu446","article-title":"A Bayesian network meta-analysis on the effect of inodilatory agents on mortality","volume":"114","author":"Greco","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.arcped.2017.12.003_bib0245","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1616218","article-title":"Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery","volume":"376","author":"Mehta","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2017.12.003_bib0250","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2017.9973","article-title":"Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: the LICORN randomized clinical trial","volume":"318","author":"Cholley","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2017.12.003_bib0255","doi-asserted-by":"crossref","first-page":"276","DOI":"10.12659\/MSM.889767","article-title":"Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure","volume":"20","author":"Tasal","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.arcped.2017.12.003_bib0260","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00246-015-1117-5","article-title":"Experience with levosimendan in 32 paediatric patients","volume":"36","author":"Vilaboa Pedrosa","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.arcped.2017.12.003_bib0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2253-11-18","article-title":"Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure","volume":"11","author":"Suominen","year":"2011","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.arcped.2017.12.003_bib0270","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1525-1594.2011.01348.x","article-title":"How mechanical circulatory support helps not to need it--new strategies in pediatric heart failure","volume":"35","author":"Schweigmann","year":"2011","journal-title":"Artif Organs"},{"key":"10.1016\/j.arcped.2017.12.003_bib0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2150135116674466","article-title":"The hemodynamic effects and safety of repetitive levosimendan infusions on children with dilated cardiomyopathy","volume":"8","author":"Suominen","year":"2017","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"10.1016\/j.arcped.2017.12.003_bib0280","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.acvd.2015.01.012","article-title":"Single-centred experience with levosimendan in paediatric decompensated dilated cardiomyopathy","volume":"108","author":"S\u00e9gu\u00e9la","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.arcped.2017.12.003_bib0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PCC.0b013e3181e2a437","article-title":"Rotating inotrope therapy in a pediatric population with decompensated heart failure","volume":"12","author":"Ryerson","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.arcped.2017.12.003_bib0290","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00540-012-1537-9","article-title":"Levosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery","volume":"27","author":"Ebade","year":"2013","journal-title":"J Anesth"},{"key":"10.1016\/j.arcped.2017.12.003_bib0295","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/PCC.0b013e3182455571","article-title":"Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study","volume":"13","author":"Lechner","year":"2012","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.arcped.2017.12.003_bib0300","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00134-012-2564-6","article-title":"Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial","volume":"38","author":"Ricci","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.arcped.2017.12.003_bib0305","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jtcvs.2011.10.072","article-title":"A decade of pediatric mechanical circulatory support before and after cardiac transplant","volume":"143","author":"Chen","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.arcped.2017.12.003_bib0310","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s12325-012-0070-4","article-title":"Economic evaluation of levosimendan versus dobutamine for the treatment of acute heart failure in Italy","volume":"29","author":"Lucioni","year":"2012","journal-title":"Adv Ther"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X17305031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X17305031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T09:25:43Z","timestamp":1535102743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X17305031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0929693X17305031"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2017.12.003","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemodynamic support of a 15-year-old waiting for a heart transplant: Is there a role for levosimendan in pediatric heart failure?","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}